
Valeo Pharma Investor Relations Material
Latest events

Q3 2024
Valeo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Valeo Pharma Inc
Access all reports
Valeo Pharma Inc. is a specialty pharmaceutical company engaged in the acquisition, in-licensing brands and sale of pharmaceutical products with primary focus on respiratory, speciality and hospital generic products in Canada. The Company's core competencies include clinical research, regulatory affairs and drug safety. The Company focuses on marketing approved products through its prescription division as well as niche markets such as respiratory through specialty divisions.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
VPH
Country
🇨🇦 Canada